|
General Information
|
|
|
Product
|
HE4 Antibody
|
|
Description
|
Affinity Purified WAP domain containing protein HE4-V2/V3 Antibody C-epitope
|
|
Verified Applications
|
ELISA, IHC, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Monkey, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 70-120 on human WAP four-disulfide core domain protein 2.
|
|
Accession #
|
NCBI: NP_006094.3
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.68 µg/µl in antibody stabilization buffer
|
|
Form
|
Affinity Purified
|
|
Clonality
|
Polyclonal
|
|
Determinant
|
C-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
DB
|
1:20,000
|
|
ELISA
|
1:20,000
|
|
Immunoprecipitation
|
1:200
|
| Immunohistochemistry |
1:200 |
|
Western Blot
|
1:500-1:750
|
|
Protein
|
|
Uniprot #
|
Q14508
|
|
Overview
|
Broad range protease inhibitor
|
|
Molecular Function
|
Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor
|
|
Subcellular Location
|
extracellular space; extracellular vesicular exosome; Secreted
|
|
Expression
|
male reproductive system; regions of the respiratory tract; nasopharynx; number of tumors cells lines, such ovarian, colon, breast, lung and renal cells lines.Initially described as being exclusively transcribed in the epididymis.
|
|
Structure
|
Homotrimer; disulfide-linked
|
|
Alternative Nomenclature
|
EDDM4
epididymal protein 4
Epididymal secretory protein E4
Epididymis specific whey acidic
type four disulfide core
HE 4
Major epididymis specific protein E4
Putative protease inhibitor WAP5
WAP domain containing protein HE4
WAP four disulfide core domain 2
WAP5
WFDC2
|
HE4 Antibody FITC
HE4 Antibody BIOTIN
HE4 Blocking Peptide
HE4 Positive Control
